6月17日 - 截至格林尼治标准时间周二上午 9 时 30 分,报导了以下竞标、兼并、收购和处置情况:
** 在伦敦上市的风险投资公司 BP Marsh 收购了伦敦专业 MGA 公司 Cameron Specialty 27% 的股份。
nL6N3SK0DF
** 据英国《金融时报》周一报导,礼来< LLY.N (link) >正与基因编辑初创公司Verve Therapeutics< VERV.O (link) >进行深入谈判,拟以不超过13亿美元的价格收购该公司,旨在加强其实验药物产品线。
nL4N3SJ1JV
** 私募股权公司KKR < KKR.N (link) >称,已同意从澳大利亚太平洋股权合伙公司(Pacific Equity Partners)、加拿大OPSEU养老金信托公司(OPSEU Pension Trust)和在伦敦上市的前瞻集团(Foresight Group < FSGF.L (link) >)组成的财团手中收购澳大利亚电力生产商Zenith Energy。
nL4N3SJ1GP
(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.